Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-15 Option Award |
2025-03-18 8:45 pm |
N/A 2035-03-15 |
Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER |
277,215 | $0 | 362,922 (Direct) |
View |
| 2024-06-03 Exercise |
2024-06-05 7:38 pm |
N/A 2029-09-10 |
Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER |
106,200 | $0 | 352,607 (Direct) |
View |
| 2024-06-03 Exercise |
2024-06-05 7:38 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER |
106,200 | $0.34 | 352,607 (Direct) |
View |
| 2024-06-03 Conversion |
2024-06-05 7:38 pm |
N/A N/A |
Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER |
141,600 | $0 | 352,607 (Direct) |
View |
| 2024-03-15 Option Award(A) |
2024-03-20 7:42 pm |
N/A 2034-03-14 |
Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER |
213,486 | $0 | 213,486 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-19 4:51 pm |
N/A 2034-03-14 |
Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER |
299,193 | $0 | 299,193 (Direct) |
View |
Ownership |
2023-02-02 6:12 pm |
N/A 2029-09-10 |
Structure Therapeutics Inc. | GPCR | Lin Xichen Chief Scientific Officer |
0 | $0 | 568,000 (Direct) |
View |